{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:36:14Z","timestamp":1790120174445,"version":"4.0.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This systematic review and meta-analysis aimed to compare outcomes of 0.01% atropine with orthokeratology (AOK) vs. orthokeratology (OK) alone for slowing the progression of myopia in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MEDLINE via PubMed, Embase, Scopus, Web of Science, CENTRAL (Cochrane Central Register of Controlled Trials), Chinese electronic databases of VIP, and Wanfang were searched from inception until 19th August 2024 for randomized controlled trials (RCTs) about the review topic. The primary outcome was a change in axial length (AL) (mm). Secondary outcomes were spherical equivalent refraction (SER) (Diopter), pupil diameter (PD) (mm), amplitude of accommodation (AA) (Diopter), and intraocular pressure (IOP) (mmHg).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>10 articles corresponding to eight RCTs were included. Meta-analysis found that change in AL was significantly reduced with AOK as compared to OK alone at 6 months (MD: \u22120.10 95% CI: \u22120.14, \u22120.06 I<jats:sup>2<\/jats:sup>\u2009=\u200948%), 12 months (MD: \u22120.08 95% CI: \u22120.10, \u22120.07 I<jats:sup>2<\/jats:sup>\u2009=\u20090%) and 24 months (MD: \u22120.14 95% CI: \u22120.19, \u22120.08 I<jats:sup>2<\/jats:sup>\u2009=\u20090%). Pooled analysis found that AOK did not reduce the progression of SER (MD: 0.06 95% CI: \u22120.00, 0.12 I<jats:sup>2<\/jats:sup>\u2009=\u20097%) and increased PD (MD: 0.63 95% CI: 0.40, 0.85 I<jats:sup>2<\/jats:sup>\u2009=\u200986%) as compared to OK alone. Pooled analysis also found a tendency of reduced AA with AOK as compared to OK alone but without significant results (MD: \u22120.45 95% CI: \u22121.00, 0.10 I<jats:sup>2<\/jats:sup>\u2009=\u200959%). Meta-analysis failed to show a statistically significant difference in change of IOP between AOK and OK (MD: \u22120.49 95% CI: \u22121.48, 0.50 I<jats:sup>2<\/jats:sup>\u2009=\u200951%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>AOK seems to be more efficacious in slowing the progression of myopia in children as compared to OK alone.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1571790","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:22:44Z","timestamp":1748928164000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Value of adding 0.01% atropine with orthokeratology for myopia in children: an updated meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Shudan","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangfang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet (London, England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","article-title":"Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review","volume":"157","author":"Wong","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2471\/blt.08.055673","article-title":"Potential lost productivity resulting from the global burden of uncorrected refractive error","volume":"87","author":"Smith","year":"2009","journal-title":"Bull World Health Organ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3390\/children11121548","article-title":"Pharmaceutical prescribing privileges for optometrists to combat childhood myopia in Singapore: public health policy review and analysis","volume":"11","author":"Yap","year":"2024","journal-title":"Children"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.64.6.6","article-title":"The international myopia institute ambassador group. IMI-global trends in myopia management attitudes and strategies in clinical practice\u20142022 update","volume":"64","author":"Wolffsohn","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e33341","DOI":"10.1016\/j.heliyon.2024.e33341","article-title":"Effects of orthokeratology on corneal reshaping and the delaying of axial eye growth in children","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0124535","DOI":"10.1371\/journal.pone.0124535","article-title":"Orthokeratology to control myopia progression: a meta-analysis","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10792-019-01167-9","article-title":"Changes in axial length after orthokeratology lens treatment for myopia: a meta-analysis","volume":"40","author":"Guan","year":"2020","journal-title":"Int Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/jop.2011.0017","article-title":"Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials","volume":"27","author":"Song","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.18240\/ijo.2023.08.20","article-title":"Efficacy and safety of atropine at different concentrations in prevention of myopia progression in Asian children: a systematic review and meta-analysis of randomized clinical trials","volume":"16","author":"Wei","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/ICL.0000000000000746","article-title":"The efficacy of atropine combined with orthokeratology in slowing axial elongation of myopia children: a meta-analysis","volume":"47","author":"Gao","year":"2021","journal-title":"Eye Contact Lens"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0282286","DOI":"10.1371\/journal.pone.0282286","article-title":"The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: a meta-analysis","volume":"18","author":"Wang","year":"2023","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1159\/000510779","article-title":"Combined orthokeratology with atropine for children with myopia: a meta-analysis","volume":"64","author":"Wang","year":"2021","journal-title":"Ophthalmic Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.jfma.2022.05.005","article-title":"Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis","volume":"121","author":"Tsai","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1120672121998903","article-title":"Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: a meta-analysis","volume":"32","author":"Yang","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","author":"Higgins","year":"2019","journal-title":"Cochrane Handbook for Systematic Reviews of InterventionsCochrane"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2024.1358046","article-title":"Effect of 0.01% atropine combined with orthokeratology lens on axial elongation: a 2-year randomized, double-masked, placebo-controlled, cross-over trial","volume":"11","author":"Li","year":"2024","journal-title":"Front Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-022-02635-0","article-title":"Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial","volume":"22","author":"Yu","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/bjo-2022-321272","article-title":"Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trial","volume":"107","author":"Xu","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.clae.2022.101723","article-title":"Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: a 2-year randomized clinical trial","volume":"46","author":"Tan","year":"2023","journal-title":"Contact Lens Anterior Eye"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10792-020-01658-0","article-title":"Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children","volume":"41","author":"Zhao","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B25","first-page":"1044","article-title":"Clinical observation of low-dose atropine combined with orthokeratology in the treatment of myopia | international eye science;(12): 1044-1047, 2020. | WPRIM","volume":"20","author":"Tang","year":"2020","journal-title":"Int Eye Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/opo.12730","article-title":"Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control","volume":"40","author":"Vincent","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"key":"B27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","article-title":"Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results","volume":"62","author":"Kinoshita","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","article-title":"Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial","volume":"10","author":"Kinoshita","year":"2020","journal-title":"Sci Rep"},{"key":"B29","first-page":"1102","article-title":"Effect of orthokeratology lens combined with 0.01% atropine on juvenile myopia","volume":"17","author":"Shi","year":"2017","journal-title":"J Chin Pr Diagn Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.61.14.15","article-title":"Effects of atropine treatment on choroidal thickness in myopic children","volume":"61","author":"Ye","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/iovs.65.10.21","article-title":"Choroidal changes during and after discontinuing long-term 0.01% atropine treatment for myopia control","volume":"65","author":"Lee","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s10792-021-01855-5","article-title":"Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination","volume":"41","author":"Hao","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/opo.13029","article-title":"The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: a meta-analysis","volume":"42","author":"Zheng","year":"2022","journal-title":"Ophthalmic Physiol Opt"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.11-8453","article-title":"Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study","volume":"53","author":"Hiraoka","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/02713683.2019.1568501","article-title":"Combined atropine with orthokeratology for myopia control: study design and preliminary results","volume":"44","author":"Tan","year":"2019","journal-title":"Curr Eye Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","article-title":"One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial","volume":"40","author":"Tan","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1167\/iovs.10-5716","article-title":"The effect of two-zone concentric bifocal spectacle lenses on refractive error development and eye growth in young chicks","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.visres.2009.07.011","article-title":"Relative peripheral hyperopic defocus alters central refractive development in infant monkeys","volume":"49","author":"Smith","year":"2009","journal-title":"Vision Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3341\/kjo.2016.30.6.434","article-title":"Effectiveness of toric orthokeratology in the treatment of patients with combined myopia and astigmatism","volume":"30","author":"Lyu","year":"2016","journal-title":"Korean J Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/OPX.0b013e31820f16fb","article-title":"Peripheral refraction in myopic children wearing orthokeratology and gas-permeable lenses","volume":"88","author":"Kang","year":"2011","journal-title":"Optom Vis Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/OPX.0b013e31826c1831","article-title":"Impact of pupil diameter on axial growth in orthokeratology","volume":"89","author":"Chen","year":"2012","journal-title":"Optom Vis Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/OPX.0000000000000178","article-title":"Atropine slows myopia progression more in Asian than white children by meta-analysis","volume":"91","author":"Li","year":"2014","journal-title":"Optom Vis Sci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1571790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:22:45Z","timestamp":1748928165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1571790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":42,"alternative-id":["10.3389\/fped.2025.1571790"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1571790","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"article-number":"1571790"}}